India  

Outburst in court on first day of new Amanda Knox slander trial

Sky News Wednesday, 10 April 2024
Lawyers have accused Amanda Knox of lying during an angry outburst as another slander trial against the 36-year-old started in Italy today. 
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Italy Italy Country in Southern Europe

Georgia's prime minister says 'Russian law' necessary for peace as protests continue [Video]

Georgia's prime minister says 'Russian law' necessary for peace as protests continue

The White House said it was "deeply troubled" that parliament had passed the bill. The UK, Germany, Italy and France have also all urged Georgia to withdraw it.

Credit: euronews (in English)    Duration: 02:25Published

Confident of win, PM Modi says will attend Italy G7 meet in June

PM Narendra Modi confident of overwhelming BJP victory in Lok Sabha elections, plans to attend G7 summit in Italy after taking oath as PM, as announced on Aaj..
IndiaTimes
New Analysis Suggests Long-Term Effectiveness for Wegovy Users [Video]

New Analysis Suggests Long-Term Effectiveness for Wegovy Users

New Analysis Suggests , Long-Term Effectiveness , for Wegovy Users . NBC reports that patients taking Novo Nordisk's obesity treatment maintain an average of 10% weight loss over four years. The news potentially boosts the drugmaker's push for Wegovy to be covered by insurers and governments. . The company submitted long-term findings at the European Congress on Obesity in Venice, Italy. . This is the longest study we’ve conducted so far of semaglutide for weight loss, Martin Holst Lange, Novo’s head of development, via NBC. We see that once the majority of the weight loss is accrued, you don’t go back and start to increase in weight if you stay on the drug, Martin Holst Lange, Novo’s head of development, via NBC. According to another analysis published by the drugmaker, approximately 17% of trial participants stopped using the treatment due to side effects like nausea. . The costly treatment ranges from $200 to nearly $2,000 per month in the ten countries where the drug is available. NBC reports that Novo Nordisk was the first drugmaker to market GLP-1 agonists, originally developed as a diabetes treatment, to address record high obesity rates. NBC reports that Novo Nordisk was the first drugmaker to market GLP-1 agonists, originally developed as a diabetes treatment, to address record high obesity rates. Rival Eli Lilly launched its drug Zepbound in the United States in December of 2023. . Neither drugmaker has managed to produce enough of the treatment to meet surging demand

Credit: Wibbitz Top Stories    Duration: 01:31Published
European Commission chief von der Leyen visits Rome as campaign trail continues [Video]

European Commission chief von der Leyen visits Rome as campaign trail continues

Prior to her Monday meetings with Italian political leaders, von der Leyen was a guest on national TV, where she spoke about the need to defend Ukraine against Russia's aggression to preserve peace in Europe.

Credit: euronews (in English)    Duration: 02:00Published

Tom Brady Gets Racy in Italy with Speedboat Team for Venice Grand Prix

Tom Brady's going from getting roasted to racing through the canals of Venice, Italy ... what a difference a week makes! The G.O.A.T. QB is calling the shots..
TMZ.com

Related videos from verified sources

Harvey Weinstein's Lawyer Praises Rape Conviction Reversal: "A Great Day For America" | THR News Video [Video]

Harvey Weinstein's Lawyer Praises Rape Conviction Reversal: "A Great Day For America" | THR News Video

Harvey Weinstein's lawyer is saying it's a "great day in America" after the former Hollywood mogul's rape conviction in New York was overturned. Arthur Aidala, Weinstein's lawyer in the appellate case,..

Credit: The Hollywood Reporter     Duration: 02:41Published
Campus Antisemitism Chaos, and Trump Trial Kicks Off, with Emily Jashinsky and Eliana Johnson [Video]

Campus Antisemitism Chaos, and Trump Trial Kicks Off, with Emily Jashinsky and Eliana Johnson

Megyn Kelly is joined by Emily Jashinsky, host of "The Federalist Radio Hour," and Eliana Johnson, editor of the Washington Free Beacon, to discuss former National Enquirer head David..

Credit: RumblePublished
New Yorkers React to Trump’s First Day of Trial in Manhattan Court [Video]

New Yorkers React to Trump’s First Day of Trial in Manhattan Court

We are amid an historic presidential election season not only because we are to have a rematch between Joe Biden and Donald Trump, but also because the former president is now sitting for his first..

Credit: Veuer     Duration: 01:22Published